TKO completes $800M ASR, leveraging up to return capital

What happened

TKO Group Holdings announced the completion of its $800 million accelerated share repurchase agreement, funded mostly via a $1.0 billion term loan added in September 2025. While management frames the buyback as a sign of confidence, the debt-funded capital return pushes net debt/EBITDA to 3.71x and interest coverage to 4.87x, leaving a thin margin of safety. The master report highlights that TKO's GAAP net income was a mere $6.4 million in 2024 despite $1.25 billion in Adjusted EBITDA, largely due to $401 million in legal add-backs. The ASR's completion boosts per-share metrics near term, but the leverage increase means any operational or legal misstep will hit equity harder. Overall, this move confirms the management's aggressive capital allocation approach, prioritizing buybacks over deleveraging.

Implication

The completion of the $800M ASR reduces share count by roughly 4.2 million shares, lifting EPS and free cash flow per share in upcoming quarters. However, because it was debt-funded, net debt rose to ~$2.5 billion, and net debt/EBITDA now sits at 3.71x—near the 4x threshold the master report flags as a 'decreases if' level. With interest coverage at just 4.87x, there is limited room for a revenue shortfall or a new large legal settlement before covenants tighten. The buyback also reinforces management's willingness to lever up for buybacks rather than preserve balance sheet flexibility, which raises the risk profile. Given the stock's ~29x EV/EBITDA and ~72x P/E, there is little reward for this added risk, making TKO more vulnerable to multiple compression over the next 6–12 months.

Thesis delta

The completion of the $800M leveraged buyback validates the master report's bearish thesis: management is loading up debt to return capital, not to fund growth or de-lever. This aggressive capital allocation increases downside risk if operating results disappoint or legal costs recur, making the stock's high multiple even less justified. The thesis remains a POTENTIAL SELL, with the ASR completion providing no fundamental improvement to the risk-reward trade-off and arguably worsening it.